BMJ2d
Real-world evidence is a vital tool for informing treatment strategies in chronic obstructive pulmonary disease
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
emjreviews.com2d
Early Lung Function Decline Predicts Long-Term Respiratory Symptoms
Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and ...
The Hospitalist1d
Gabapentinoid Use Associated with Increased Risk of Severe Exacerbations in Patientswith COPD
Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...
Medscape9d
The Entire Disease Continuum: The Potential of Long-Term Study Cohorts
Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...
Pharmabiz13d
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...